Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Antisense Therapeutics Limited
Health
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| +19.05% | 15 Jan 2021 |
| +19.05% | 15 Jan 2021 |
| +18.92% | 14 Jan 2021 |
| +11.11% | 11 Jan 2021 |
| 0.00% | 18 Dec 2020 |
| -13.33% | 17 Dec 2020 |
| -13.33% | 17 Dec 2020 |
| +19.57% | 13 Dec 2020 |
| -4.00% | 07 Dec 2020 |
| 0.00% | 03 Dec 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,048
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:ANP is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia